Boston Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Boston
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Boston News
New hub for deep tech innovation launches in downtown Boston
Base-X is opening its doors on Wednesday, a new hub for startups with long and uncertain R&D phases, requiring large amounts of capital before coming up with an innovation grounded in science and ...
How To Watch and Listen To Georgia Tech vs Boston College
It’s game day, and the Yellow Jackets have another opportunity ahead of them when they go on the road to face Boston College. Georgia Tech will look to keep pac ...
Boston life science procurement platform Labviva named a 2025 BostInno Blazer
As tariffs have impacted the supply chain, LabViva CEO Siamak Baharloo says his company is helping life sciences and pharmaceutical companies to expand their supply networks.
Boston Scientific, Siemens Healthineers partner on cardiac catheter
Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston Scientific’s Watchman device.